Delivery Order SPE2DB22D2206-SPE2DB25FKD63
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $21,382.17 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for Columvi 10 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with performance to be completed by August 27, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger indefinite delivery contract vehicle. This delivery order is issued under...
- The Defense Logistics Agency awarded a $21,382.17 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Columvi 10 mg/10 mL vials. The contract, which represents no set-aside designation, has an ultimate completion date of September 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Columvi 10 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $21,382.17 and is scheduled for completion by September 9, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was used in this award. This delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,535.20 to AmerisourceBergen Drug Corp on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price, non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $10,473.58 from the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $52,252.74 by the Defense Logistics Agency's Medical Supply Chain on September 1, 2025, with a completion date of September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $42,325.67 on August 11, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX. The award was made through...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,022.44 to AmerisourceBergen Drug Corp on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,197.66 to AmerisourceBergen Drug Corp on August 9, 2025, with completion scheduled for August 11, 2025. This firm fixed-price, non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order valued at $12,821.24 to AmerisourceBergen Drug Corp on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled at...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKD63Delivery Order
The Defense Logistics Agency awarded a $52,869.34 delivery order to AmerisourceBergen Drug Corp on September 28, 2025, for the supply of Columvi 10 mg/10 mL vials. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of October 20, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated substantial capacity to meet federal medical procurement requirements through its extensive portfolio of deliveries to the Defense Logistics Agency and related military healthcare organizations. This delivery order reflects the company's role in supplying specialty pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The competitive award of this order, consistent with the company's track record of non-set-aside contracts, underscores AmerisourceBergen's capability to fulfill federal medical supply needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.9k | 9/28/25 |